0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Human Health Effects Sign in to save

Engineering Organ-on-a-Chip Systems for Vascular Diseases

Arteriosclerosis Thrombosis and Vascular Biology 2023 48 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 60 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Amid Shakeri, Ying Wang, Yimu Zhao, Shira Landau, K. Perera, Jonguk Lee, Milica Radisic

Summary

This review covers organ-on-a-chip technology, which creates miniature models of blood vessels on microchips to study diseases like atherosclerosis and blood clots. While not directly about microplastics, this technology is increasingly being used to study how microplastics and nanoplastics affect human blood vessels and organs in controlled laboratory settings. These advanced models could help researchers better understand the health risks of microplastic exposure without relying solely on animal studies.

Body Systems
Models
Study Type In vivo

Vascular diseases, such as atherosclerosis and thrombosis, are major causes of morbidity and mortality worldwide. Traditional in vitro models for studying vascular diseases have limitations, as they do not fully recapitulate the complexity of the in vivo microenvironment. Organ-on-a-chip systems have emerged as a promising approach for modeling vascular diseases by incorporating multiple cell types, mechanical and biochemical cues, and fluid flow in a microscale platform. This review provides an overview of recent advancements in engineering organ-on-a-chip systems for modeling vascular diseases, including the use of microfluidic channels, ECM (extracellular matrix) scaffolds, and patient-specific cells. We also discuss the limitations and future perspectives of organ-on-a-chip for modeling vascular diseases.

Sign in to start a discussion.

Share this paper